AAAAAA
Results:
1-17
|
Results: 17
Authors:
Fiedorowicz, A
Figiel, L
Kaminska, B
Zaremba, M
Wilk, S
Oderfeld-Nowak, B
Citation: A. Fiedorowicz et al., Dentate granule neuron apoptosis and glia activation in murine hippocampusinduced by trimethyltin exposure, BRAIN RES, 912(2), 2001, pp. 116-127
Authors:
Ostrowska, H
Wojcik, C
Wilk, S
Omura, S
Kozlowski, L
Stoklosa, T
Worowski, K
Radziwon, P
Citation: H. Ostrowska et al., Separation of cathepsin A-like enzyme and the proteasome: evidence that lactacystin/beta-lactone is not a specific inhibitor of the proteasome, INT J BIO C, 32(7), 2000, pp. 747-757
Authors:
Flinkman, M
Michalowski, W
Nilsson, S
Slowinski, R
Susmaga, R
Wilk, S
Citation: M. Flinkman et al., Use of Rough Sets analysis to classify Siberian forest ecosystems according to net primary production of phytomass, INFOR, 38(3), 2000, pp. 145-160
Authors:
Golab, J
Stoklosa, T
Czajka, A
Dabrowska, A
Jakobisiak, M
Zagozdzon, R
Wojcik, C
Marczak, M
Wilk, S
Citation: J. Golab et al., Synergistic antitumor effects of a selective proteasome inhibitor and TNF in mice, ANTICANC R, 20(3A), 2000, pp. 1717-1721
Authors:
Krzanowska, EK
Znamensky, V
Wilk, S
Bodnar, RJ
Citation: Ek. Krzanowska et al., Antinociceptive and behavioral activation responses elicited by D-Pro(2)-Endomorphin-2 in the ventrolateral periaqueductal gray are sensitive to sex and gonadectomy differences in rats, PEPTIDES, 21(5), 2000, pp. 705-715
Authors:
Wilk, S
Chen, WE
Magnusson, RP
Citation: S. Wilk et al., Properties of the beta subunit of the proteasome activator PA28 (11S REG), ARCH BIOCH, 384(1), 2000, pp. 174-180
Authors:
Wilk, S
Chen, WE
Magnusson, RP
Citation: S. Wilk et al., Properties of the nuclear proteasome activator PA28 gamma (REG gamma), ARCH BIOCH, 383(2), 2000, pp. 265-271
Authors:
Orlowski, M
Wilk, S
Citation: M. Orlowski et S. Wilk, Catalytic activities of the 20 S proteasome, a multicatalytic proteinase complex, ARCH BIOCH, 383(1), 2000, pp. 1-16
Authors:
Wilk, S
Chen, WE
Wojcik, C
Magnusson, RP
Citation: S. Wilk et al., Proteasome activators and synthetic modulators: Significance for antigen presentation, MOL B INT U, 12, 2000, pp. 137-153
Authors:
Wilk, S
Chen, WE
Magnusson, RP
Citation: S. Wilk et al., Modulators of the activation of the proteasome by PA28 (11S Reg), MOL BIOL RP, 26(1-2), 1999, pp. 39-44
Authors:
Wojcik, C
Wilk, S
Citation: C. Wojcik et S. Wilk, Changes in proteasome expression and activity during differentiation of neuronal precursor NTera 2 clone D1 cells, NEUROCHEM I, 34(2), 1999, pp. 131-136
Authors:
Yamanaka, C
Lebrethon, MC
Vandersmissen, E
Gerard, A
Purnelle, G
Lemaitre, M
Wilk, S
Bourguignon, JP
Citation: C. Yamanaka et al., Early prepubertal ontogeny of pulsatile gonadotropin-releasing hormone (GnRH) secretion: I. Inhibitory autofeedback control through prolyl endopeptidase degradation of GnRH, ENDOCRINOL, 140(10), 1999, pp. 4609-4615
Authors:
Stoklosa, T
Wojcik, C
Golab, J
Giermasz, A
Wilk, S
Citation: T. Stoklosa et al., Inhibition of proteasome, apoptosis and sensitization to tumour necrosis factor alpha: do they always go together?, BR J CANC, 79(2), 1999, pp. 375-376
Authors:
Shane, R
Wilk, S
Bodnar, RJ
Citation: R. Shane et al., Modulation of endomorphin-2-induced analgesia by dipeptidyl peptidase IV, BRAIN RES, 815(2), 1999, pp. 278-286
Authors:
Wojcik, C
Mlynarczuk, I
Hoser, G
Kawiak, J
Stoklosa, T
Golab, J
Wilk, S
Citation: C. Wojcik et al., A combination of retinoic acid and proteasome inhibitors for the treatmentof leukemias is potentially dangerous, BLOOD, 94(5), 1999, pp. 1827-1828
Authors:
Barelli, H
Petit, A
Hirsch, E
Wilk, S
De Nanteuil, G
Morain, P
Checler, F
Citation: H. Barelli et al., S17092-1, a highly potent, specific and cell permeant inhibitor of human proline endopeptidase, BIOC BIOP R, 257(3), 1999, pp. 657-661
Authors:
Wilk, S
Chen, WE
Magnusson, RP
Citation: S. Wilk et al., Modulation of the PA28 alpha-20S proteasome interaction by a peptidyl alcohol, ARCH BIOCH, 362(2), 1999, pp. 283-290
Risultati:
1-17
|